Nov. 16, 2015 – From tax inversions to the proposal to reduce ad tax deductions for marketing to being named an “enemy” by Hillary Clinton, it is clear that as the march toward the 2016 presidential election continues, the potential changes ahead for pharmaceutical companies could be substantial, according to two industry experts speaking at […]
Read more